Charles Brandes acquired 5.06 Million Pfizer shares worth $145 Million. That's 1.90% of their equity portfolio (11th largest holding). The first Pfizer trade was made in Q1 2013. Since then Charles Brandes bought shares sixteen more times and sold shares on 28 occasions. The investor's estimated purchase price is $153 Million, resulting in a loss of 5.1%.